SCHEMBL3072968

SCHEMBL3072968

CCOC(=O)P(=O)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2987558 0.76
SCHEMBL1378510 0.76
SCHEMBL28563163 0.75 ALDH1A1 (0.42)
SCHEMBL2991782 0.74
SCHEMBL28471443 0.74 ALDH1A1 (0.46)
Ethyl Acetate SCHEMBL23500866 0.74 ALDH1A1 (0.74)
SCHEMBL28467229 0.74 ALDH1A1 (0.46)
SCHEMBL2982561 0.74 ALDH1A1 (0.46)
Disodium Ethoxycarbonylphosphonate SCHEMBL10886559 0.72 ALDH1A1 (0.43)
SCHEMBL2240528 0.72 CA12 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116583529-A Abiraterone derivative and preparation method thereof 上海喀露蓝科技有限公司 2023-08-11 CN claimed
US-12397058-B2 Metabolically stable prodrugs TSRL, INC. (US) 2025-08-26 US disclosed
US-12391711-B2 Tetrahydrocannabinol derivatives, preparation method thereof and use thereof CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) 2025-08-19 US disclosed
CN-114644673-B Estradiol derivative, preparation method thereof and application thereof in medicine 上海喀露蓝科技有限公司 2023-12-26 CN disclosed
CN-116583529-A Abiraterone derivative and preparation method thereof 上海喀露蓝科技有限公司 2023-08-11 CN disclosed
US-20230227482-A1 TETRAHYDROCANNABINOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) 2023-07-20 US disclosed
EP-4089081-A1 TETRAHYDROCANNABINOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) 2022-11-16 EP disclosed
CN-114644673-A Estradiol derivative, preparation method and medical application thereof 上海喀露蓝科技有限公司 2022-06-21 CN disclosed
US-20210401992-A1 METABOLICALLY STABLE PRODRUGS TSRL, INC. (US) 2021-12-30 US disclosed
CN-112390821-B Propofol phosphamide derivative, preparation method and medical application thereof 四川夏派森医药科技有限公司 2021-11-02 CN disclosed
WO-2002007780-A2 METHODS FOR IDENTIFYING THERAPEUTIC TARGETS NEWBIOTICS, INC. (US) 2002-01-31 WO disclosed
EP-1135401-A1 GLYCERYL NUCLEOTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE SCHOTT, Herbert (DE) 2001-09-26 EP disclosed
WO-2000034298-A1 GLYCERYL NUCLEOTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE SCHOTT HERBERT (DE) 2000-06-15 WO disclosed
WO-1998016537-A1 NOVEL COMPOUNDS ASTRA AKTIEBOLAG (PUBL) (SE) 1998-04-23 WO disclosed
US-5166386-A Inhibit cholesterol biosynthesis E. R. SQUIBB & SONS, INC. (US) 1992-11-24 US disclosed
US-5132414-A DIDEOXYNUCLEOSIDE-5'-PHOSPHONOFORMIC ACID COMPOUNDS DANA-FARBER CANCER INSTITUTE, INC. (US) 1992-07-21 US disclosed
US-5107011-A Intermediates for anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1992-04-21 US disclosed
EP-0456468-A2 Complex of dideoxynucleoside and phosphonoformic acid DANA-FARBER CANCER INSTITUTE, INC. (US) 1991-11-13 EP disclosed
US-5025003-A Anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1991-06-18 US disclosed
EP-0418814-A2 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method for preparing the same E.R. SQUIBB &amp; SONS, INC. (US) 1991-03-27 EP disclosed